中文
Log in
UK REACH Authorisation List (Annex 14)
Entries: 54
Items: 98
Last update: Jan 16, 2024
Entry number
CAS number
English substance name
EC No.
Sunset Date
Details
1
81-15-2
5-tert-butyl-2,4,6-trinitro-m-xylene (Musk xylene)
201-329-4
21/08/2014
More
2
101-77-9
4,4’- Diaminodiphenylmethane (MDA)
202-974-4
21/08/2014
More
3
Hexabromocyclododecane (HBCDD)
-
21/08/2015
More
25637-99-4
Hexabromocyclododecane
247-148-4
21/08/2015
More
134237-52-8
gamma-hexabromocyclododecane
-
21/08/2015
More
3194-55-6
1,2,5,6,9,10-hexabromocyclododecane
221-695-9
21/08/2015
More
134237-50-6
alpha-hexabromocyclododecane
-
21/08/2015
More
134237-51-7
beta-hexabromocyclododecane
-
21/08/2015
More
4
117-81-7
Bis(2-ethylhexyl) phthalate (DEHP)
204-211-0
21/02/2015
More
5
85-68-7
Benzyl butyl phthalate (BBP)
201-622-7
21/02/2015
More
UK REACH Authorisation List (Annex 14)
Annex 14 of the UK REACH Regulation is a copy of Annex XIV of the EU REACH Regulation as it stood at the end of the transition period, and the existing EU list of authorized substances (Annex XIV) has been retained under UK REACH. The authorization provisions in UK REACH are designed to promote the gradual replacement of Substances of Very High Concern (SVHCs) with substances or technologies that present a lower risk. According to Article 58(3) of the Regulation, the UK Health and Safety Executive (HSE) must recommend priority substances from the SVHC candidate list to be included in the authorization list (Annex 14). Substances included in the authorization list require authorization after the sunset date for certain uses or to be placed on the UK market, unless an exemption has already been granted for that use.
Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline